Clinical Trial

Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients

Study acronym: SAF-NRVS
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the efficacy and safety of steroids treatment compared with placebo in preserving facial nerve function after craniotomy in patients with vestibular schwannoma who have not received preoperative treatment and have good intraoperative facial nerve function.
Trial Details
NCT Number NCT07116811
Lead Sponsor Beijing Tiantan Hospital
Conditions Vestibular Schwannoma, Facial Nerve Paralysis
Enrollment 364 participants
Start Date 2025-09-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-12